Avi Eliassaf
Direttore operativo presso Anima Biotech, Inc.
Profilo
Avi Eliassaf is currently the Chief Operating Officer at Anima Biotech, Inc. Previously, he worked as the Chief Financial Officer at SalesPredict SW Ltd.
He completed his undergraduate degree at Ben-Gurion University of the Negev.
Posizioni attive di Avi Eliassaf
| Società | Posizione | Inizio |
|---|---|---|
Anima Biotech, Inc.
 Anima Biotech, Inc. Pharmaceuticals: MajorHealth Technology Anima Biotech, Inc. develops translation control therapeutics, a new class of drugs that specifically control protein translation as a novel strategy against hard and undruggable targets. The firm?s platform combines new biology with proprietory image analysis and big data software. The company was founded Yochi Slonim and Zeev Smilansky and is headquartered in Bernardsville, NJ. | Direttore operativo | - |
Precedenti posizioni note di Avi Eliassaf
| Società | Posizione | Fine |
|---|---|---|
SalesPredict SW Ltd.
 SalesPredict SW Ltd. Electronics DistributorsDistribution Services SalesPredict SW Ltd. developed predictive analytics solutions. The firm offered solution for marketing, sale and customer management. The company was founded by Yaron Zakai-Or and Kira Radinsky in 2012 and was headquartered in Netanya, Israel. | Direttore Finanziario/CFO | - |
Formazione di Avi Eliassaf
| Ben-Gurion University of the Negev | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
SalesPredict SW Ltd.
SalesPredict SW Ltd. Electronics DistributorsDistribution Services SalesPredict SW Ltd. developed predictive analytics solutions. The firm offered solution for marketing, sale and customer management. The company was founded by Yaron Zakai-Or and Kira Radinsky in 2012 and was headquartered in Netanya, Israel. | Distribution Services |
Anima Biotech, Inc.
Anima Biotech, Inc. Pharmaceuticals: MajorHealth Technology Anima Biotech, Inc. develops translation control therapeutics, a new class of drugs that specifically control protein translation as a novel strategy against hard and undruggable targets. The firm?s platform combines new biology with proprietory image analysis and big data software. The company was founded Yochi Slonim and Zeev Smilansky and is headquartered in Bernardsville, NJ. | Health Technology |
- Borsa valori
- Insiders
- Avi Eliassaf
